Vident Advisory’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Sell |
1,982
-805
| -29% | -$111K | ﹤0.01% | 1350 |
|
|
2025
Q1 | $502K | Buy |
2,787
+295
| +12% | +$53.2K | 0.01% | 1028 |
|
|
2024
Q4 | $390K | Sell |
2,492
-83
| -3% | -$13K | 0.01% | 1068 |
|
|
2024
Q3 | $469K | Buy |
2,575
+610
| +31% | +$111K | 0.01% | 954 |
|
|
2024
Q2 | $361K | Buy |
1,965
+549
| +39% | +$101K | 0.01% | 1052 |
|
|
2024
Q1 | $252K | Buy |
+1,416
| New | +$252K | 0.01% | 1113 |
|